By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Indalo Therapeutics 

4320 Forest Park Avenue
Suite 304
St. Louis  Missouri  63108  U.S.A.
Phone: 314-932-4032 X317 Fax: n/a


SEARCH JOBS

Indalo Therapeutics is a preclinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating fibrotic diseases. Founded on groundbreaking scientific discoveries and leveraging cutting-edge insight into the molecular drivers of aberrant scarring, Indalo is harnessing the collective experience of a seasoned team of pharmaceutical scientists and executives to tackle some of the most urgent unmet medical needs in the fibrosis space.

YEAR FOUNDED:

2014

LEADERSHIP:

CMO: Williamson Z. Bradford, M.D., Ph.D.

CSO and Board Member: Scott D. Seiwert, Ph.D.

Sr. VP of Pharmaceutical Development: Ramachandran Radhakrishnan, Ph.D.

Sr. VP of Translational Science: Karl Kossen, Ph.D.

VP and Head of Business Operations: George H. Capps, M.S., M.B.A.


Key Statistics


Email:
Ownership: Private

Web Site: Indalo Therapeutics
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->